Your browser doesn't support javascript.
loading
A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children.
Bélard, Sabine; Issifou, Saadou; Hounkpatin, Aurore B; Schaumburg, Frieder; Ngoa, Ulysse Ateba; Esen, Meral; Fendel, Rolf; de Salazar, Pablo Martinez; Mürbeth, Raymund E; Milligan, Paul; Imbault, Nathalie; Imoukhuede, Egeruan Babatunde; Theisen, Michael; Jepsen, Søren; Noor, Ramadhani A; Okech, Brenda; Kremsner, Peter G; Mordmüller, Benjamin.
Affiliation
  • Bélard S; Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon.
PLoS One ; 6(7): e22525, 2011.
Article in En | MEDLINE | ID: mdl-21829466
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Protozoan Proteins / Malaria, Falciparum / Malaria Vaccines / Antigens, Protozoan Type of study: Clinical_trials Limits: Child / Child, preschool / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2011 Type: Article Affiliation country: Gabon
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Protozoan Proteins / Malaria, Falciparum / Malaria Vaccines / Antigens, Protozoan Type of study: Clinical_trials Limits: Child / Child, preschool / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2011 Type: Article Affiliation country: Gabon